2012 annual financial data

Alnylam Pharmaceuticals 2012 Financial results

Direct answer

Revenue was 66.73M USD.

Operating income was -129.46M USD and net income was -106.01M USD.
Operating cash flow was -115.61M USD.

Get free Alnylam Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
66.73M USD
Operating income
-129.46M USD
Net income
-106.01M USD
Operating cash flow
-115.61M USD